Methocarbamol NDC 55154-2335

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-2335Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-2335Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-2335-0	55154233500	10 BLISTER PACK in 1 BAG (55154-2335-0) / 1 TABLET in 1 BLISTER PACKMarketed from Jan 15, 2013

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 750 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cardinal Health 107, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086988
Marketing start: Jan 15, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 55154-2335_c940cc69-23a3-4796-8127-74e5cf6c819cSPL ID c940cc69-23a3-4796-8127-74e5cf6c819cSPL set ID 50603730-9f69-4ed7-bccf-31c474f83e14RxCUI 197943, 197944UNII 125OD7737XUPC 0055154233507
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154233500 followed by a unit qualifier and the quantity

Package 55154-2335-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 086988

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 086988
Product	Strength	Form · route	Labeler	Product NDC
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Proficient Rx LP	63187-130
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Bryant Ranch Prepack	71335-1727
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Solco Healthcare LLC	43547-405
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	REMEDYREPACK INC.	70518-4472
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Major Pharmaceuticals	0904-7057
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Major Pharmaceuticals	0904-7058
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Bryant Ranch Prepack	63629-8995
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-598
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Solco Healthcare LLC	43547-226
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Cardinal Health 107, LLC	55154-2334
Methocarbamol	Methocarbamol 750 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-468
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-467